LBDDSLinked Birth Death Data Set
References in periodicals archive ?
Lipid-based drug delivery systems (LBDDS) incorporated into softgel technologies are frequently used to improve the bioavailability of poorly soluble compounds, and have been used successfully to bring more than 50 poorly soluble molecules to market.
The basic principles of LBDDS technology, which has proven to be one of the most successful advanced drug delivery methods applied to BCS Class II drugs, ensure that drug substances are delivered in a solution form that is maintained within biological fluids before the API reaches the intestinal membrane.
To cater to this need, Catalent initiated research into the application of LBDDS technology for the non-invasive delivery of biologic drugs back in 2007.